<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04198168</url>
  </required_header>
  <id_info>
    <org_study_id>1-10-72-75-19</org_study_id>
    <nct_id>NCT04198168</nct_id>
  </id_info>
  <brief_title>The Predictive Performance of Renal Ultrasound on Changes in Renal Clearance</brief_title>
  <official_title>The Predictive Performance of Renal Ultrasonographic Perfusion Measures on Changes in Renal Clearance in Response to Fluid Therapy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aarhus University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aarhus University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will examine the ability of renal ultrasound (Doppler and Contrast Enhanced&#xD;
      Ultrasound (CEUS)) in distinguishing ICU patients who exhibit increases in glomerular&#xD;
      filtration rate (GFR) in response to fluid loading, from those for whom fluid loading is&#xD;
      without benefit of directly harmful.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will examine the ability of renal ultrasound (Doppler and Contrast Enhanced&#xD;
      Ultrasound (CEUS)) in distinguishing ICU patients who exhibit increases in GFR in response to&#xD;
      fluid loading, from those for whom fluid loading is without benefit of directly harmful.&#xD;
&#xD;
      Patients available for inclusion will receive a baseline administration of Tc-99-DTPA for&#xD;
      precise determination of GFR/renal function by blood and urine samples.&#xD;
&#xD;
      Baseline values of ultrasound measures will be obtained, including renal arterial, renal&#xD;
      venous, portal venous and hepatic venous Doppler measures and renal contrast enhanced&#xD;
      ultrasound (CEUS) will also be recorded.&#xD;
&#xD;
      After two hours, baseline values of GFR are finished. The patient is then exposed to passive&#xD;
      leg raising and ultrasound measures are repeated, including renal arterial, renal venous,&#xD;
      portal venous and hepatic venous Doppler measures.&#xD;
&#xD;
      The participant then receives a standardised fluid bolus of 7 ml/kg (ideal body weight) Once&#xD;
      the fluid bolus administration is complete, renal ultrasound is repeated, including renal&#xD;
      arterial, renal venous, portal venous, hepatic venous Doppler measures and renal CEUS.&#xD;
&#xD;
      Follow-up determination of GFR/renal function based on Tc-99-DTPA after fluid therapy is&#xD;
      repeated with blood and urine samples.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Due to the COVID-19 situation, it was not feasible to complete the study in our ICU.&#xD;
  </why_stopped>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Actual">November 30, 2020</completion_date>
  <primary_completion_date type="Actual">November 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in renal function in response to a standardised fluid bolus.</measure>
    <time_frame>6 hours</time_frame>
    <description>Renal function is measures as Tc-99-Diethylenetriaminepentaacetic acid (DTPA) clearance.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Renal venous flow classification</measure>
    <time_frame>6 hours</time_frame>
    <description>normal - abnormal (pulsatile/biphasic/monophasic</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal venous impedance index</measure>
    <time_frame>6 hours</time_frame>
    <description>(maximum flow velocity - minimum diastolic flow velocity) / maximum flow velocity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal venous stasis index</measure>
    <time_frame>6 hours</time_frame>
    <description>(index cardiac cycle time - venous flow time) / index cardiac cycle time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal arterial resistive index</measure>
    <time_frame>6 hours</time_frame>
    <description>(maximum flow velocity - minimum diastolic flow velocity) / maximum flow velocity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Portal venous pulsatility fraction</measure>
    <time_frame>6 hours</time_frame>
    <description>(maximum flow velocity - minimum diastolic flow velocity) / maximum flow velocity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Contrast enhanced ultrasound 1</measure>
    <time_frame>6 hours</time_frame>
    <description>Mean transit time (mTT)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Contrast enhanced ultrasound 2</measure>
    <time_frame>6 hours</time_frame>
    <description>Perfusion Index (PI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Contrast enhanced ultrasound 3</measure>
    <time_frame>6 hours</time_frame>
    <description>Relative Blood Volume (rBV)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Contrast enhanced ultrasound 4</measure>
    <time_frame>6 hours</time_frame>
    <description>Wash-in Rate (WiR)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Contrast enhanced ultrasound 5</measure>
    <time_frame>6 hours</time_frame>
    <description>Quality Of Fit (QOF)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Continuous recordings of hemodynamic variables 1</measure>
    <time_frame>6 hours</time_frame>
    <description>arterial pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Continuous recordings of hemodynamic variables 2</measure>
    <time_frame>6 hours</time_frame>
    <description>Central venous pressure</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">2</enrollment>
  <condition>Acute Kidney Injury</condition>
  <condition>Hypoperfusion</condition>
  <condition>Fluid Overload</condition>
  <arm_group>
    <arm_group_label>ICU patients</arm_group_label>
    <description>ICU patients who are assessed by their attending physician as having need for fluid therapy and are planned to receive IV crystalloid fluid due to oliguria and/or to improve GFR.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IV crystalloid fluid bolus</intervention_name>
    <description>The participant receives IV fluid as a standardised bolus of 7 ml/kg (ideal body weight).</description>
    <arm_group_label>ICU patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients admitted to the ICU at Aarhus University Hospital&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients â‰¥ 18 years admitted to the ICU, Aarhus University Hospital.&#xD;
&#xD;
          -  Patients who are assessed by their attending physician as having need for fluid&#xD;
             therapy.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Insufficient ultrasound imaging of the kidneys.&#xD;
&#xD;
          -  Pregnancy.&#xD;
&#xD;
          -  Intolerance to any ultrasound contrast agent or isotopes, including intolerance for&#xD;
             human albumin.&#xD;
&#xD;
          -  Prior enrolment in a conflicting research study.&#xD;
&#xD;
          -  Known morphological kidney disease.&#xD;
&#xD;
          -  Need for dialysis.&#xD;
&#xD;
          -  Need for extracorporeal membrane oxygenation (ECMO).&#xD;
&#xD;
          -  Prior participation.&#xD;
&#xD;
          -  Severe pulmonary hypertension (systolic pulmonary pressure &gt; 90 mmHg)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Aarhus University Hospital, Department of Anaesthesiology</name>
      <address>
        <city>Aarhus</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>November 8, 2019</study_first_submitted>
  <study_first_submitted_qc>December 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 13, 2019</study_first_posted>
  <last_update_submitted>December 7, 2020</last_update_submitted>
  <last_update_submitted_qc>December 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aarhus University Hospital</investigator_affiliation>
    <investigator_full_name>Johan Fridolf Hermansen</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Ultrasound</keyword>
  <keyword>Renal perfusion</keyword>
  <keyword>Fluid treatment</keyword>
  <keyword>Venous congestion</keyword>
  <keyword>Renal function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

